Drug Profile


Alternative Names: EF4; efamol

Latest Information Update: 19 Nov 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Scotia Holdings [CEASED]
  • Class Herbal medicines
  • Mechanism of Action Prostaglandin synthase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Diabetic neuropathies

Most Recent Events

  • 19 Nov 1999 Discontinued-preregistration for Diabetic neuropathies in European Union (PO)
  • 16 Jan 1998 Appeal for approval of tarabetic has been turned down by the MCA
  • 16 Oct 1997 Scotia has resubmitted the application for approval
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top